ArticleBritish journal of pharmacology2020

JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.

Xiunan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.